JPH1046142A - Antioxidant - Google Patents
AntioxidantInfo
- Publication number
- JPH1046142A JPH1046142A JP8216734A JP21673496A JPH1046142A JP H1046142 A JPH1046142 A JP H1046142A JP 8216734 A JP8216734 A JP 8216734A JP 21673496 A JP21673496 A JP 21673496A JP H1046142 A JPH1046142 A JP H1046142A
- Authority
- JP
- Japan
- Prior art keywords
- antioxidant
- extract
- cosmetics
- saxifraga
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 33
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 29
- 241000220151 Saxifragaceae Species 0.000 claims abstract description 7
- 244000288377 Saxifraga stolonifera Species 0.000 claims abstract description 5
- 235000002953 Saxifraga stolonifera Nutrition 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 241000220156 Saxifraga Species 0.000 claims description 11
- 239000000419 plant extract Substances 0.000 claims description 6
- 238000013329 compounding Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 18
- 239000000203 mixture Substances 0.000 abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 11
- 239000002537 cosmetic Substances 0.000 abstract description 11
- 239000000284 extract Substances 0.000 abstract description 10
- 241000196324 Embryophyta Species 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- 238000010992 reflux Methods 0.000 abstract description 2
- 230000003389 potentiating effect Effects 0.000 abstract 2
- 239000000047 product Substances 0.000 abstract 2
- 244000078641 Hydrangea opuloides Species 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000007654 immersion Methods 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 20
- 239000003921 oil Substances 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000012071 phase Substances 0.000 description 9
- -1 rinses Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 244000267823 Hydrangea macrophylla Species 0.000 description 4
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 4
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000208251 Gymnema Species 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- VCUVETGKTILCLC-UHFFFAOYSA-N 5,5-dimethyl-1-pyrroline N-oxide Chemical compound CC1(C)CCC=[N+]1[O-] VCUVETGKTILCLC-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- 241001647091 Saxifraga granulata Species 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 2
- 241000475042 Stolonifera Species 0.000 description 2
- 241000270666 Testudines Species 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 241000792914 Valeriana Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000001570 sorbitan monopalmitate Substances 0.000 description 2
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 2
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 235000017468 valeriana Nutrition 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 description 1
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000020694 echinacea extract Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 238000007342 radical addition reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規にして、かつ
優れた抗酸化作用を有する抗酸化剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel antioxidant having an excellent antioxidant action.
【0002】[0002]
【従来の技術および発明が解決しようとする課題】従
来、油脂を含む食品や化粧品等の抗酸化剤として、ジブ
チルヒドロキシトルエン(BHT)、ブチルヒドロキシ
アニソール(BHA)、トコフェロール等が使用されて
いる。しかしBHT、BHA等の合成抗酸化剤は、安全
性上の問題があり、添加量等が制限されている。そのた
め天然系の抗酸化剤が望まれていた。本発明はこのよう
な従来の事情に対処してなされたもので、抗酸化剤とし
ての効果が高く、しかも毒性上の問題がなく、食品や化
粧品、医薬品原料等としても用いることのできる安全性
の高い抗酸化剤を提供することを目的とする。BACKGROUND OF THE INVENTION Hitherto, dibutylhydroxytoluene (BHT), butylhydroxyanisole (BHA), tocopherol and the like have been used as antioxidants for foods and cosmetics containing oils and fats. However, synthetic antioxidants such as BHT and BHA have safety problems, and the amount added is limited. Therefore, natural antioxidants have been desired. The present invention has been made in view of such conventional circumstances, has a high effect as an antioxidant, has no toxicity problem, and can be used as food, cosmetics, pharmaceutical raw materials and the like. It is intended to provide an antioxidant having a high content.
【0003】[0003]
【課題を解決するための手段】本発明者は上記の目的達
成のため、天然物の抗酸化活性を鋭意検討した結果、ユ
キノシタ科のユキノシタ(学名:Saxifraga stolonifer
a )植物抽出物が抗酸化剤として極めて有効であること
を見い出した。Means for Solving the Problems In order to achieve the above object, the present inventors have intensively studied the antioxidant activity of natural products, and as a result, it was found that Saxifraga stolonifer (scientific name: Saxifraga stolonifer) of the family Saxifragaceae.
a) The plant extract was found to be extremely effective as an antioxidant.
【0004】即ち、本発明は、ユキノシタ科のユキノシ
タ(学名:Saxifraga stolonifera)植物抽出物を有効
成分とすることを特徴とする抗酸化剤である。[0004] That is, the present invention is an antioxidant characterized by containing a plant extract of Saxifraga stolonifera of the family Saxifragaceae as an active ingredient.
【0005】以下、本発明の構成について詳述する。本
発明に用いられるユキノシタ科のユキノシタ(学名:Sa
xifraga stolonifera )植物抽出物は、いずれも従来よ
りテストステロン−5α−レダクターゼ阻害作用、美白
作用、抗炎症作用のあることが知られており(特開平5
−17365号公報、特開平5−58870号、特開平
5−139951号公報)、化粧料中に配合されてきた
ものである。しかしながらこれらの成分に抗酸化作用が
あることは未だ知られておらず、本発明者がはじめて見
い出したものである。Hereinafter, the configuration of the present invention will be described in detail. Saxifragaceae of the family Saxifragaceae used in the present invention (scientific name: Sa
All of the xifraga stolonifera) plant extracts have been known to have a testosterone-5α-reductase inhibitory effect, a whitening effect, and an anti-inflammatory effect (Japanese Patent Application Laid-open No. Hei 5 (1993) -107).
-17365, JP-A-5-58870, JP-A-5-139951), and cosmetics. However, it is not yet known that these components have an antioxidant action, and they have been found for the first time by the present inventors.
【0006】本発明に用いられるユキノシタ(学名:Sa
xifraga stolonifera )植物は、特に日本(北海道を除
く)、中国の山間部の陰湿な岩上に多く分布する多年草
植物である。本発明に用いられる抽出物は、上記植物の
葉と茎又は果実等、ユキノシタ全草を抽出溶媒と共に冷
浸または加熱還流した後、ろ過し、濃縮して得られる。
本発明に用いられる抽出溶媒は、通常抽出に用いられる
溶媒であれば何でもよく、特に水、あるいは1,3−ブ
タンジオール、エタノール、メタノール等のアルコール
類、含水アルコール類、アセトン、酢酸エチル等の有機
溶媒を単独あるいは組み合わせて用いることができる。[0006] Saxifraga (scientific name: Sa) used in the present invention
The xifraga stolonifera) plant is a perennial plant that is distributed abundantly on humid rocks especially in the mountains of Japan (excluding Hokkaido) and China. The extract used in the present invention is obtained by subjecting the whole plant, such as the leaves and stems or fruits of the above plants, to saxifrage seeds to cold soaking or heating to reflux with an extraction solvent, followed by filtration and concentration.
The extraction solvent used in the present invention may be any solvent as long as it is a solvent usually used for extraction, particularly water, or alcohols such as 1,3-butanediol, ethanol and methanol, hydrous alcohols, acetone and ethyl acetate. Organic solvents can be used alone or in combination.
【0007】本発明におけるユキノシタ抽出物の配合量
は、外用剤全量中、乾燥物として0.001〜20.0
重量%が適当である。0.001重量%未満では抗酸化
力が不十分であり、20.0重量%を超えて使用するこ
とは抗酸化力の点では不必要であり、一方、商品に臭い
が生じて使用性が悪くなったりするので実際的ではな
い。The amount of the Saxifraga extract in the present invention is 0.001 to 20.0% as a dry matter in the total amount of the external preparation.
% By weight is appropriate. If it is less than 0.001% by weight, the antioxidant power is insufficient, and if it exceeds 20.0% by weight, it is unnecessary in terms of antioxidant power. It is not practical because it gets worse.
【0008】抗酸化剤として配合する対象物としては化
粧料が好ましく、抗酸化作用の必要な各種化粧品、例え
ばクリーム、ローション、乳液、ヘアオイル、シャンプ
ー、リンス、石鹸等に添加すると優れた抗酸化力を発揮
する。このような化粧料中に添加する他の添加剤として
は、例えば、油分、界面活性剤、増粘剤、中和剤、防腐
剤、粉体成分、色素、金属イオン封鎖剤、香料、紫外線
吸収剤、薬効剤などが挙げられ、必要に応じて適宜組み
合わせて用いられる。当然のことながら、本発明の抗酸
化剤はビタミンE、甘草抽出物、BHT、BHA等の他
の抗酸化剤と、本発明の効果を損なわない範囲内におい
て併用可能である。[0008] Cosmetics are preferred as the object to be blended as an antioxidant, and when added to various cosmetics requiring an antioxidant effect, for example, creams, lotions, emulsions, hair oils, shampoos, rinses, soaps, etc., have excellent antioxidant power. Demonstrate. Other additives to be added to such cosmetics include, for example, oils, surfactants, thickeners, neutralizers, preservatives, powder components, pigments, sequestering agents, fragrances, and ultraviolet absorption. Agents, medicinal agents, etc., and are used in appropriate combinations as needed. As a matter of course, the antioxidant of the present invention can be used in combination with other antioxidants such as vitamin E, licorice extract, BHT, and BHA as long as the effects of the present invention are not impaired.
【0009】特に、本発明の抗酸化剤を用いれば、従来
酸化安定性が悪く配合が困難とされてきた物質であって
も安定的に系中に配合できるようになる。例えば、化粧
品に応用するとエモリエント効果等が期待されるタート
ル油、ミンク油等は酸化安定性が悪く、その利用には制
限があったが、これらの油脂を配合した化粧品に本発明
の抗酸化剤を添加することによって、油脂を酸化から防
ぐことができ、これらの油脂を化粧品中に有効に配合す
ることができる。また、最近は生体系における脂質過酸
化反応防止を目的として、抗酸化剤適用の提案もされて
いるが、本発明の抗酸化剤も勿論生体系への利用が可能
である。In particular, the use of the antioxidant of the present invention makes it possible to stably mix even a substance which has conventionally been considered difficult to mix due to poor oxidation stability. For example, turtle oil, mink oil, and the like, which are expected to have an emollient effect when applied to cosmetics, have poor oxidative stability, and their use is limited. By adding, the fats and oils can be prevented from being oxidized, and these fats and oils can be effectively incorporated into cosmetics. Recently, application of an antioxidant has been proposed for the purpose of preventing lipid peroxidation reaction in a biological system, but the antioxidant of the present invention can of course be used in a biological system.
【0010】[0010]
【作用】ユキノシタ科のユキノシタ(学名:Saxifraga
stolonifera )植物抽出物の抗酸化力が強いことは、本
発明者らによる以下の実験から確認された。[Action] Saxifraga of the family Saxifragaceae (scientific name: Saxifraga
stolonifera) The strong antioxidant activity of the plant extract was confirmed by the following experiments by the present inventors.
【0011】(1)ヒドロキシラジカル消去活性試験 1mMの硫酸第1鉄(FeSO4 )溶液50μlと、表
1記載の試料(水溶液)75μlの混合液に5,5−ジ
メチル−1−ピロリンオキサイド(DMPO)の10%
水溶液20μlを加え、続いて1mM過酸化水素( H2
O2)75μlを加え、攪拌した。H2 O2 を添加してか
ら75秒後に発生したヒドロキシラジカル(・OH)の
ラジカル付加体(DMPO−OH)を電子スピン共鳴装
置(ESR)を用いて測定した。なお、ヒドロキシラジ
カルの消去活性は蒸留水のヒドロキシラジカルの消去活
性を0%として求めた。その結果を表1に示す。なお表
中、カノコソウ、ギムネマおよびアマチャは、いずれも
天然系の抗酸化剤として知られているものであり、特に
アマチャについては、本発明のユキノシタ科のユキノシ
タ(学名:Saxifraga stolonifera )植物と同じユキノ
シタ科ではあるがアジサイ属(学名:Hydrangea serrat
a )植物として比較対照した。(1) Hydroxy Radical Scavenging Activity Test A mixture of 50 μl of a 1 mM ferrous sulfate (FeSO 4 ) solution and 75 μl of a sample (aqueous solution) shown in Table 1 was mixed with 5,5-dimethyl-1-pyrroline oxide (DMPO). 10% of
An aqueous solution (20 μl) was added, followed by 1 mM hydrogen peroxide (H 2
O 2 ) was added and stirred. Radical addition of hydroxyl radicals generated from the addition of H 2 O 2 after 75 seconds (· OH) and (DMPO-OH) was measured using an electron spin resonance apparatus (ESR). The hydroxyl radical scavenging activity was determined on the assumption that the hydroxyl radical scavenging activity of distilled water was 0%. Table 1 shows the results. In the table, valerian, gymnema and amacha are all known as natural antioxidants. Hydrangea (scientific name: Hydrangea serrat)
a) Comparative control as a plant.
【0012】[0012]
【表1】 ───────────────────────────────── ヒドロキシラジカル消去活性 ───────────────────────────────── コントロール(水) 0% カノコソウ(10mg/ml ) 8% ギムネマ(10mg/ml ) 23% アマチャ(10mg/ml ) 30% ユキノシタ(10mg/ml ) 60% ─────────────────────────────────[Table 1] ヒ ド ロ キ シ Hydroxy radical scavenging activity───────── ──────────────────────── Control (water) 0% Valeriana (10mg / ml) 8% Gymnema (10mg / ml) 23% Amacha (10mg / ml) ml) 30% Sakinoshita (10mg / ml) 60% ─────────────────────────────────
【0013】(2)スーパーオキシド消去活性試験 表2記載の試料(水溶液)5μlに発色試薬50μlお
よび酵素液50μlを加え、37度で20分間静置した
後、反応停止液100μlを添加し、570nmでの吸
光度を測定した。ただし、発色試薬は、0.1Mリン酸
緩衝液pH8、0.4mMキサンチン、0.24mMニ
トロブルーテトラゾリウムの混合液とする。また酵素液
は、0.049U/mlキサンチンオキシダーゼとす
る。反応停止液は69mMドデシル硫酸ナトリウムとす
る。またスーパーオキシド消去活性は標準SODによる
消去率に換算して求めた。その結果を表2に示す。(2) Superoxide scavenging activity test To 5 μl of the sample (aqueous solution) shown in Table 2, 50 μl of a coloring reagent and 50 μl of an enzyme solution were added, and the mixture was allowed to stand at 37 ° C. for 20 minutes. The absorbance at was measured. However, the coloring reagent is a mixture of 0.1 M phosphate buffer pH 8, 0.4 mM xanthine, and 0.24 mM nitro blue tetrazolium. The enzyme solution is 0.049 U / ml xanthine oxidase. The reaction stop solution is 69 mM sodium dodecyl sulfate. The superoxide erasing activity was determined by converting it to the erasing rate by standard SOD. Table 2 shows the results.
【0014】[0014]
【表2】 ───────────────────────────────── スーパーオキシド消去活性 ───────────────────────────────── コントロール(水) 0 U /ml カノコソウ(10mg/ml ) 0 U /ml ギムネマ(10mg/ml ) 0 U /ml アマチャ(10mg/ml ) 7 U /ml ユキノシタ(10mg/ml ) 22 U /ml ─────────────────────────────────[Table 2] ───────────────────────────────── Superoxide scavenging activity ───────── ──────────────────────── Control (water) 0 U / ml Valeriana (10 mg / ml) 0 U / ml Gymnema (10 mg / ml) 0 U / ml amateur (10mg / ml) 7U / ml saxinosita (10mg / ml) 22U / ml ──────────────────────────── ─────
【0015】[0015]
【実施例】以下に実施例によって、本発明を更に具体的
に説明するが、本発明はこの実施例に限定されるもので
はない。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.
【0016】 実施例1 乳液 ステアリン酸 2.5重量% セチルアルコール 1.5 ワセリン 5.0 流動パラフィン 7.0 タートル油 3.0 ポリオキシエチレン(10モル)モノオレイン酸エステル 2.0 ポリエチレングリコール1500 3.0 トリエタノールアミン 1.0 ユキノシタの1,3−ブチレングリコール抽出物 0.02 香料 適量 防腐剤 適量 精製水 残余 (製法)イオン交換水にポリオキシエチレングリコール
1500とトリエタノールアミンを加え、加熱溶解して
70℃に保つ(水相)。他の成分を混合し、加熱融解し
て70℃に保つ(油相)。水相に油相を加え、ホモミキ
サーで均一に乳化し、乳化後、よくかき混ぜながら30
℃まで冷却して乳液を得た。Example 1 Emulsion Stearic acid 2.5% by weight Cetyl alcohol 1.5 Vaseline 5.0 Liquid paraffin 7.0 Turtle oil 3.0 Polyoxyethylene (10 mol) monooleate 2.0 Polyethylene glycol 1500 3.0 Triethanolamine 1.0 1,3-butylene glycol extract of Saxifraga 0.02 Fragrance Appropriate amount Preservatives Appropriate amount Purified water residue (Production method) Add polyoxyethylene glycol 1500 and triethanolamine to ion-exchanged water and heat. Dissolve and maintain at 70 ° C. (aqueous phase). The other components are mixed, heated and melted and kept at 70 ° C. (oil phase). Add oil phase to water phase, emulsify uniformly with homomixer, and after emulsification, stir well
C. to give an emulsion.
【0017】 実施例2 クリーム ミツロウ 10.0重量% セチルアルコール 5.0 水添ラノリン 5.0 スクワラン 37.5 ミンク油 3.0 グリセリルモノステアリン酸エステル 2.0 ポリオキシエチレン(20モル) ソルビタンモノラウリン酸エステル 2.0 プロピレングリコール 5.0 ユキノシタのエタノール抽出物 0.02 香料 適量 防腐剤 適量 精製水 残余 (製法)イオン交換水にプロピレングリコールを加え、
加熱して70℃に保つ(水相)。他の成分を混合し、加
熱融解して70℃に保つ(油相)。水相に油相を加えて
予備乳化を行い、ホモミキサーで均一に乳化した後、よ
くかき混ぜながら30℃まで冷却してクリームを得た。Example 2 Cream Beeswax 10.0% by weight Cetyl alcohol 5.0 Hydrogenated lanolin 5.0 Squalane 37.5 Mink oil 3.0 Glyceryl monostearate 2.0 Polyoxyethylene (20 mol) Sorbitan monolaurin Acid Ester 2.0 Propylene Glycol 5.0 Echinacea extract of Saxifraga 0.02 Perfume Appropriate Preservative Appropriate Purified Water Residue (Production method) Add propylene glycol to ion-exchanged water,
Heat and maintain at 70 ° C. (aqueous phase). The other components are mixed, heated and melted and kept at 70 ° C. (oil phase). The oil phase was added to the water phase to carry out preliminary emulsification, and after uniform emulsification with a homomixer, the mixture was cooled to 30 ° C. while stirring well to obtain a cream.
【0018】 実施例3 クリーム セトステアリルアルコール 3.5重量% スクワラン 40.0 ミツロウ 3.0 還元ラノリン 5.0 エチルパラベン 0.3 ポリオキシエチレン(20モル) ソルビタンモノパルミチン酸エステル 2.0 ステアリン酸モノグリコシド 2.0 ユキノシタの30%エタノール抽出物 5.0 香料 0.03 1,3−ブチレングリコール 5.0 グリセリン 5.0 ヒアルロン酸ナトリウム 0.05 精製水 残余 (製法)セトステアリルアルコール、スクワラン、ミツ
ロウ、還元ラノリン、エチルパラベン、ポリオキシエチ
レン(20モル)ソルビタンモノパルミチン酸エステ
ル、ステアリン酸モノグリコシド、ユキノシタ抽出物お
よび香料を加熱溶解し、75℃に保ったものを、75℃
に加温した1,3−ブチレングリコール、グリセリン、
ヒアルロン酸ナトリウムおよび精製水に撹拌しながら加
える。ホモミキサー処理し、乳化粒子を細かくした後、
撹拌しながら急冷し、クリームを得た。Example 3 Cream Cetostearyl alcohol 3.5% by weight Squalane 40.0 Beeswax 3.0 Reduced lanolin 5.0 Ethyl paraben 0.3 Polyoxyethylene (20 mol) Sorbitan monopalmitate 2.0 Stearic acid Monoglycoside 2.0 30% ethanol extract of Saxifraga 5.0 Perfume 0.03 1,3-butylene glycol 5.0 Glycerin 5.0 Sodium hyaluronate 0.05 Purified water Residue (Production method) Cetostearyl alcohol, squalane, Beeswax, reduced lanolin, ethylparaben, polyoxyethylene (20 mol) sorbitan monopalmitate, stearic acid monoglycoside, saxifrage extract and perfume were heated and dissolved, and the mixture kept at 75 ° C was heated to 75 ° C.
1,3-butylene glycol, glycerin heated to
Add to sodium hyaluronate and purified water with stirring. After homogenizing the mixture and making the emulsified particles smaller,
The mixture was rapidly cooled with stirring to obtain a cream.
【0019】 実施例4 乳液 ユキノシタのアセトン抽出物 1.0重量% ステアリン酸 1.5 セチルアルコール 0.5 ミツロウ 2.0 ポリオキシエチレン(10モル) モノオレイン酸エステル 1.0 ステアリン酸モノグリコシド 1.0 クインスシード抽出液(5%水溶液) 20.0 プロピレングリコール 5.0 エタノール 3.0 エチルパラベン 0.3 メチルパラベン 0.05 香料 0.05 精製水 残余 (製法)エタノールにユキノシタのアセトン抽出物、香
料を加えて溶解する(アルコール溶液)。精製水にプロ
ピレングリコールを加え加熱溶解して70℃に保つ(水
相)。クインスシード抽出液を除く他の成分を混合し、
加熱溶解して70℃に保つ(油相)。水相に油相を加え
予備乳化を行い、ホモミキサーで均一に乳化する。これ
を撹拌しながらアルコール溶液とクインスシード抽出液
を加える。その後撹拌しながら30℃に急冷して乳液を
得た。Example 4 Latex Acetone Extract of Saxifraga 1.0 wt% 1.5 stearic acid 1.5 cetyl alcohol 0.5 beeswax 2.0 polyoxyethylene (10 mol) monooleate 1.0 stearic acid monoglycoside 1 0.0 Quinseed extract (5% aqueous solution) 20.0 Propylene glycol 5.0 Ethanol 3.0 Ethylparaben 0.3 Methylparaben 0.05 Perfume 0.05 Purified water Residue (Production method) Acetone extract of Saxifraga in ethanol, Add flavor and dissolve (alcohol solution). Propylene glycol is added to purified water, and the mixture is dissolved by heating and maintained at 70 ° C. (aqueous phase). Mix other ingredients except quince seed extract,
Heat and dissolve and maintain at 70 ° C (oil phase). The oil phase is added to the water phase, pre-emulsified, and homogenized uniformly with a homomixer. While stirring, the alcohol solution and the quince seed extract are added. Thereafter, the mixture was rapidly cooled to 30 ° C. with stirring to obtain an emulsion.
【0020】[0020]
【発明の効果】以上説明したように、本発明によれば、
従来の抗酸化剤に比較して顕著な酸化防止効果を発現す
ることができるとともに、同じユキノシタ科のアマチャ
に比較しても極めて強い抗酸化効果を示した。また、本
発明の抗酸化物を用いれば、酸化安定性が悪く配合が困
難とされてきた物質であっても安定的に系中に配合でき
るようになり、化粧品や食品等、広い範囲での利用が期
待される。As described above, according to the present invention,
A remarkable antioxidant effect was able to be exhibited as compared with the conventional antioxidant, and an extremely strong antioxidant effect was also shown as compared with the same safflower family. Further, if the antioxidant of the present invention is used, even a substance which has been considered difficult to compound due to poor oxidation stability can be stably compounded in the system, and can be used in a wide range of cosmetics and foods. Use is expected.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/78 ADN A61K 35/78 ADN ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location A61K 35/78 ADN A61K 35/78 ADN
Claims (2)
fraga stolonifera)植物抽出物を有効成分とすること
を特徴とする抗酸化剤。The present invention relates to a Saxifragaceae family (scientific name: Saxi
fraga stolonifera) An antioxidant comprising a plant extract as an active ingredient.
01〜20.0重量%である請求項1記載の抗酸化剤。2. The compounding amount of the Saxifraga plant extract is 0.0
The antioxidant according to claim 1, wherein the amount is from 01 to 20.0% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8216734A JPH1046142A (en) | 1996-07-30 | 1996-07-30 | Antioxidant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8216734A JPH1046142A (en) | 1996-07-30 | 1996-07-30 | Antioxidant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH1046142A true JPH1046142A (en) | 1998-02-17 |
Family
ID=16693101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8216734A Withdrawn JPH1046142A (en) | 1996-07-30 | 1996-07-30 | Antioxidant |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH1046142A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000002526A1 (en) * | 1997-04-25 | 2000-01-20 | Kanebo Limited | Pack preparation |
| ES2352403A1 (en) * | 2009-07-27 | 2011-02-18 | Caroi'line Cosmetica, S.L. | Extracts of saxifraga spathularis, process of obtaining and its cosmetic, pharmaceutical and/or food use as antioxidants/antirradicalarios/uv filters (ultraviolet). (Machine-translation by Google Translate, not legally binding) |
| JP2016529206A (en) * | 2013-05-10 | 2016-09-23 | ザ プロクター アンド ギャンブル カンパニー | Consumer products containing silane-modified oil |
| JP2018162235A (en) * | 2017-03-27 | 2018-10-18 | 株式会社マンダム | Anti-whitening agent |
| CN113087608A (en) * | 2021-03-08 | 2021-07-09 | 中国科学院西北高原生物研究所 | New diaryl nonane V, VI and VII free radical inhibitor in saxifraga tangutica and separation preparation process and application thereof |
-
1996
- 1996-07-30 JP JP8216734A patent/JPH1046142A/en not_active Withdrawn
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000002526A1 (en) * | 1997-04-25 | 2000-01-20 | Kanebo Limited | Pack preparation |
| US6723667B1 (en) | 1997-04-25 | 2004-04-20 | Kanebo, Ltd. | Pack preparation |
| ES2352403A1 (en) * | 2009-07-27 | 2011-02-18 | Caroi'line Cosmetica, S.L. | Extracts of saxifraga spathularis, process of obtaining and its cosmetic, pharmaceutical and/or food use as antioxidants/antirradicalarios/uv filters (ultraviolet). (Machine-translation by Google Translate, not legally binding) |
| JP2016529206A (en) * | 2013-05-10 | 2016-09-23 | ザ プロクター アンド ギャンブル カンパニー | Consumer products containing silane-modified oil |
| JP2018162235A (en) * | 2017-03-27 | 2018-10-18 | 株式会社マンダム | Anti-whitening agent |
| CN113087608A (en) * | 2021-03-08 | 2021-07-09 | 中国科学院西北高原生物研究所 | New diaryl nonane V, VI and VII free radical inhibitor in saxifraga tangutica and separation preparation process and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3135943B2 (en) | Whitening agent | |
| JP3480952B2 (en) | External preparation for skin | |
| JP2002121112A (en) | External preparation for skin | |
| JPH1017435A (en) | Antioxidant composition | |
| JPH108049A (en) | Antioxidant composition | |
| JP2572730B2 (en) | Skin cosmetics | |
| US5567419A (en) | Stabilized cosmetic compositions containing monoacyl phosphatide and a saponin | |
| JPH0532556A (en) | Skin agent for external use | |
| JPH1046143A (en) | Antioxidant | |
| JPH11171723A (en) | Antioxidant | |
| JPH1017436A (en) | Skin preparation for external use | |
| EP0375082A2 (en) | Cosmetic composition | |
| JP2891727B2 (en) | Hair restoration | |
| JP3660833B2 (en) | Blood circulation promoter | |
| JPH1045528A (en) | Antioxidant | |
| JPH09315988A (en) | Antioxidant | |
| JP3270219B2 (en) | External preparation for skin | |
| JPH01149706A (en) | Skin-beautifying cosmetic | |
| JPH06219958A (en) | Melanogenesis suppressing agent and external agent for skin | |
| EP0595949A1 (en) | COMPOSITIONS FOR PIGMENTATION OF THE SKIN OR HAIR CONTAINING A VULGARIAN MARRUBIUM EXTRACT. | |
| JP2811479B2 (en) | Hair restoration | |
| JPH0782134A (en) | Cosmetic for preventing damage by ultraviolet ray | |
| JPH04356416A (en) | Skin cosmetic | |
| JP2906270B2 (en) | External preparation for skin | |
| JPH1192331A (en) | External preparation for skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20031007 |